Dean and Vice President for Medical Affairs, Chicago Medical School

Dr. Archana Chatterjee joined Rosalind Franklin University in April 2020 and is Dean of the Chicago Medical School and Vice President for Medical Affairs. For the previous 7 years, she served as Professor and Chair of the Department of Pediatrics and Senior Associate Dean for Faculty Development at the University of South Dakota Sanford School of Medicine (USD SSOM), Sioux Falls, SD. She has spent nearly 12 years as a leader in Faculty Affairs/Faculty Development (FA/FD), initially at Creighton University School of Medicine, and later at USD SSOM.

Dr. Chatterjee has been elected/selected to serve on several national Advisory Boards and Committees including the US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee, the Association of American Medical Colleges’ Group on Women in Medicine and Science, the Pediatric Infectious Diseases Society Board of Directors and the American Board of Pediatrics Sub- board of Pediatric Infectious Diseases.

Mentorship and sponsorship of faculty and learners has been a hallmark of Dr. Chatterjee’s entire thirty- year career in academic medicine. Through her tireless efforts at guiding, promoting and encouraging faculty and learners, she has impacted the careers of numerous leaders, faculty members, fellows, residents, and students, not only at her home institutions, but nationally and internationally. In addition, she has focused some of her scholarly effort on collaborative projects related to faculty and leadership development, participating in presentations at national conferences and publishing her work in high- impact, peer-reviewed journals.

Trained as a pediatric infectious disease specialist, Dr. Chatterjee has practiced in her field for over 20 years, conducted over 120 clinical trials, published over 90 peer-reviewed articles, 26 invited review articles, 24 book chapters and one book. She serves as a reviewer for 35 journals. In the past 20 years, Dr. Chatterjee has delivered over 700 lectures and 175 scientific presentations at various international, national, regional, and local venues. She has served as the course director for over 30 CME programs, given over 55 media interviews and published 25 newspaper articles.

CEO and President, Dartmouth-Hitchcock and Dartmouth-Hitchcock Health

“Organizations with diverse leadership teams perform better financially. So it is a bit confounding why it has taken so long to achieve equity in leadership, especially in healthcare. It is not a pipeline problem: Women make up more than 50 percent of physicians in training, and 78 percent of the entire healthcare workforce. It is not an ambition gap: Women in healthcare are just as interested in advancing in their careers, but less likely to be promoted. The “motherhood penalty” for women with children (stereotypes and biases about working mothers) is real.

We don’t want to simplify the challenge by just asserting that women make better leaders than men. Instead, we want to stress that greater representation by women and attention to the environment at the top of an organization allows everyone to be empowered, engaged, included, and respected in their pursuit of improving health and health care for the greater community.”

Before Dartmouth-Hitchcock, Dr. Conroy served as CEO of Lahey Hospital and Medical Center in Burlington, Mass. Prior to her leadership role at Lahey, Dr. Conroy served for more than five years as chief health care officer for the Association of American Medical Colleges in Washington, D.C. Before that, she worked at the not-for-profit Atlantic Health System in Florham Park, N.J., where she served as chief medical officer for four years; as vice president, academic affairs for three; and executive vice president for another three. Prior to these roles, Dr. Conroy served as senior associate dean, chair of the Department of Anesthesia and Perioperative Medicine, and vice president for medical affairs at the Medical University of South Carolina (MUSC).

She received her undergraduate degree in chemistry from Dartmouth College in Hanover, N.H., and her medical degree from MUSC, where she completed her residency in anesthesiology.

Dean Emerita, Case Western Reserve University School of Medicine

A renowned physician and medical researcher, Pamela B. Davis, MD, PhD, became dean of the School of Medicine and senior vice president for medical affairs at Case Western Reserve University in 2007 after serving as interim dean during the previous year. She served in this position until stepping down in 2020 to serve as a Professor in the Center for Community Health Integration. She holds the Arline H. and Curtis F. Garvin Research Professorship. She previously served as a professor of pediatrics, physiology and biophysics and a professor of molecular biology and microbiology at the university, and as chief of the pediatric pulmonary division at Rainbow Babies and Children’s Hospital and as director of the Willard A. Bernbaum Cystic Fibrosis Research Center at Case Western Reserve University.

In 2014, Dean Davis, a prolific researcher whose work focuses largely on cystic fibrosis, was proud to be inducted into the Institute of Medicine, now known as the National Academy of Medicine. She was also elected as the 2015 Chair of the Medical Sciences Section of the American Association for the Advancement of Science. In 2020 she was inducted into the National Academy of Inventors. For more than 30 years, Dean Davis has been continuously funded by the NIH, most recently as the principal investigator of the school’s $64.6 million Clinical and Translational Science Award (CTSA) program. In 2015, she began serving as the program’s co-principal investigator.

Dean Davis holds seven U.S. patents and is a founding scientist of Copernicus Therapeutics Inc., a biotechnology company that creates novel pharmaceutical targeting and delivery systems. She has published more than 130 articles in peer-reviewed journals. She has served in prominent roles such as the Advisory Council to the National Institute of Diabetes and Digestive and Kidney Diseases, the Board of Scientific Counselors for the National Heart, Lung and Blood Institute and the Advisory Council for National Center for Advancing Translational Sciences. She received her BS in chemistry, summa cum laude, from Smith College in 1968. She earned her doctorate in physiology and pharmacology in 1973 and her medical degree in 1974, both from Duke University.

DIO/Director/Associate Dean of Graduate Medical Education (Ret.) & Emerita Director of Resident/Fellow Well-being, Yale New Haven Hospital and Yale School of Medicine

Dr. Fisher served as the Designated Institutional Official (DIO)/Director/Associate Dean of Graduate Medical Education at Yale New Haven Hospital (YNHH) and Yale School of Medicine (YLM) from 1998 – 2016. In this role, she oversaw approximately 100 training programs and 1100 trainees. She became the first Director of Resident/Fellow Well-Being at Yale, where she established an innovative peer support group. She is currently a Deputy Title IX Coordinator in the Provost’s Office of Yale University. Nationally, she has held leadership roles with APDIM, the AAMC, the ACGME and its Internal Medicine Residency Review Committee, the GI Drugs Advisory Committee of the Food and Drug Administration, the American Board of Internal Medicine, and the American College of Gastroenterology.

She has been recognized for excellence in the field of Gastroenterology and for her leadership, especially as regards medical education. Her honors include the Janssen Award for Outstanding Achievement in Clinical Gastroenterology (1996), the Accreditation Council of Graduate Medical Education (ACGME) Parker J. Palmer Courage to Lead Award (2006), the Association of Program Directors of Internal Medicine (APDIM) Dema Daley Founder’s Award (2011), and the Association of American Medical Colleges (AAMC) Distinguished Service Member Award (2017). She was elected as a Master of the American College of Physicians (ACP) and honored with the George Thornton Outstanding Teacher Award and the Laureate Award of the Connecticut Chapter of the ACP. In 2017, YNHH and YSM established the Rosemarie L. Fisher, MD Award for Leadership in Graduate Medical Education, of which she was the first recipient. In 2018, the Section of Digestive Diseases established an annual named lectureship in her honor. In 2020, the Connecticut Chapter of the ACP established the Rosemarie L. Fisher, MD, Female Physician Leadership Award, of which she was the first recipient.

Dr. Fisher received her M.D. from Tufts University School of Medicine, completed her residency in Internal Medicine at Montefiore Medical Center, Bronx, NY, and trained in gastroenterology at the Royal Free Hospital, London and at Yale University.

President Emeritus, Rush University
Dean & Distinguished Professor Emeritus, Rutgers Robert Wood Johnson Medical School

Dr. Gabriel is University Professor of the Future of Health Outcomes and Medicine at Arizona State University and Board member at Online Med Ed. She is president emeritus of Rush University and dean & distinguished professor emeritus of Rutgers Robert Wood Johnson (RWJ) Medical School. She is also former CEO of the RWJ Medical Group. Having started her career at Mayo Clinic as a resident physician, Dr. Gabriel continued there as a physician, researcher, educator, and leader for nearly 30 years, culminating in her promotion to dean of Mayo Medical School in 2012. She is dean and distinguished professor emeritus at Mayo Clinic.

Her research, largely funded by the National Institutes of Health, has resulted in more than 250 original, peer-reviewed publications addressing the costs, causes, and outcomes of rheumatic diseases. Dr. Gabriel is past president of the American College of Rheumatology (ACR) and has served on many national committees, including the NIH Advisory Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; chair of the FDA Drug Safety and Risk Management Committee; and as founding chair of the Methodology Committee of the U.S. Government Accountability Office’s Patient-Centered Outcomes Research Institute. She is a member of the Association of American Physicians. Dr. Gabriel has received many honors and awards, including the ACR Henry Kunkel Young Investigator Award and the Mayo Clinic Distinguished Educator Award.

Dr. Gabriel completed her undergraduate education at the University of Regina, Saskatchewan, Canada, and the College of Pharmacy at the University of Saskatchewan Medical School before earning her medical degree at the medical school. She completed her residency in internal medicine and her fellowship in rheumatology at the Mayo Graduate School of Medicine. She also holds a master’s in clinical epidemiology from McMaster University, and completed executive education courses at the Wharton School at the University of Pennsylvania and the Kellogg School of Management at Northwestern University.

President & CEO, Center for Women in Academic Medicine and Science
President, Foundation for the Advancement of International Medical Education and Research

Over her 35 years in academic medicine, Dr. Mladenovic has served in several leadership roles, all of which have given her a broad understanding of the multitude of issues that shape the trajectory of women’s careers in medicine and science. She is passionately committed to advancing opportunities for women to flourish in academic medicine. She recently served as President of the Foundation for the Advancement of International Medical Education and Research, and in her last academic position, she served as Executive Vice-President and Provost at Oregon Health Sciences University (OHSU), where she developed creative faculty and science initiatives, a new school of public health, an interprofessional rural campus, and a university-wide partnership in Southeast Asia. Previously she held positions as senior associate dean at two institutions, and as chairman or chief of medicine. The creation of mutually beneficial partnerships between the academic health center and its communities were the hallmark of her efforts.

Dr. Mladenovic graduated from the University of Washington and its medical school. She trained in internal medicine and hematology at Johns Hopkins Hospital, Stanford University, and the University of Washington, where she also served as chief resident. For 18 years, she had an NIH/VA funded laboratory focused on hematopoietic cell differentiation. Nationally, she held leadership roles in the APM, ABIM, ABMS, ASH, ACGME, and SUSME. She holds an MBA from the University of Miami, and is a certified mediator. Currently she also serves on a university board and those of two start-ups. She and her husband of 42 years have four adult children.

Founding Director, Hedwig van Ameringen Executive Leadership in Academic Medicine® Program for Women (ELAM®), Drexel University College of Medicine

Page S. Morahan, PhD, is Founding Director of the ELAM® Program for Women and Professor Emerita in microbiology and immunology at Drexel University College of Medicine. She is also Founding Co-Director of the Foundation for Advancement of International Medical Education and Research (FAIMER®) Institute and continues to consult with FAIMER.

Dr. Morahan consults and conducts research in: design, implementation, and evaluation of leadership development programs; strategic career planning; faculty affairs, especially changing academic culture to embrace an expanded definition of research and scholarship; and advancement of women. She has directed numerous grants in both biomedical and social science, and authored over 150 peer reviewed publications.

Dr. Morahan served as Chair of the Department of Microbiology and Immunology for ten years, and founded and served as Associate Provost for Faculty Affairs at predecessor organizations of Drexel. She was the first woman President of the Association of Medical School Microbiology and Immunology Chairs in 1990. Dr. Morahan was an American Council on Education (ACE) Fellow in 1992-93, and has received certification in several organizational and personnel developmental processes.

She has served on various committees and taskforces of the National Board of Medical Examiners, Association of American Medical Colleges (AAMC), National Institutes of Health (NIH), and American Society for Microbiology. Her national honors include: NIH Research Career Development Award; AAMC Women in Medicine Leadership Development Award; ACE Office of Women in Higher Education, Network Annual Leadership Award; Fellow in American Women in Science (AWIS); Fellow of American Academy of Microbiology; Distinguished Career Award from Agnes Scott College, and Graduate Student Alumna of the Year Award from the Medical College of Wisconsin. Local honors include: Lindback Award for teaching excellence and Eli Abrutyn, MD Mentoring Award from Drexel University College of Medicine; and Elizabeth W. Bingham Mentoring Award from Philadelphia AWIS. She is also a member of the Forum of Executive Women in Philadelphia and WIL of Greater Philadelphia (Women International Leaders). Dr. Morahan received her BS, magna cum laude, from Agnes Scott College; MA, from Hunter College; and PhD in Microbiology from Marquette University (now Medical College of Wisconsin).

President, Albert and Mary Lasker Foundation

Claire Pomeroy is president and CEO of the Albert and Mary Lasker Foundation which is dedicated to accelerating support for medical research. As an infectious disease physician, she is passionate about caring for the underserved, strengthening public health infrastructure and addressing the social determinants of health.  Dr. Pomeroy was inducted into the National Academy of Medicine in 2011.

She currently serves on the Board of the Morehouse School of Medicine; Science Philanthropy Alliance; Science Communication Lab; and the Center for Women in Academic Medicine and Science. She also serves on the Board of Directors for Sierra Health Foundation, Haemonetics Corporation, and Embecta Corporation, positions for which she receives compensation.

Dr. Pomeroy received her medical degree from the University of Michigan and completed her residency and fellowship at the University of Minnesota. She earned an MBA from the University of Kentucky. She received honorary degrees from University of Massachusetts Medical School (2016) and the University of South Florida Morsani School of Medicine (2022). Previous positions include chief of infectious diseases and associate dean for research at the University of Kentucky. She was vice chancellor and dean of the University of California, Davis School of Medicine from 2005 – 2013. She became president of the Lasker Foundation in June 2013.

Dean Emerita, University of Minnesota Medical School

Dr. Powell is dean emerita of the University of Minnesota Medical School and professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota Medical School, where she coordinates the medical school pathology curriculum. At the University of Minnesota, Dr. Powell instituted the medical school’s Flexible M.D. program, an individualized model of medical education designed to be more adaptable to students’ career and learning goals.

Dr. Powell served as chair of the AAMC Board of Directors from 2009-10 and was the first female chair of the AAMC Council of Deans in 2004. She received the AAMC 2013 Abraham Flexner Distinguished Service to Medical Education Award. She is currently working on a pilot study of a new model for training medical students who want to go into pediatrics in a competency-based model that combines UME and GME. It is being tested in four U.S. medical schools, currently including the University of Minnesota. Dr. Powell was elected to the Institute of Medicine in 2000. Prior to moving to Minnesota, she was executive dean and assistant vice chancellor for clinical affairs at the University of Kansas School of Medicine. She also served as chair of the Department of Pathology at the University of Kentucky.

Dr. Powell has long been committed to supporting careers of women in academic medicine, mentoring both junior and senior women and as dean, involving Minnesota in the Brandeis C-Change project and working with AAMC Women in Medicine.

Former CEO, Virginia Commonwealth University Health System

Dr. Rappley has over 30 years of experience in academic medicine and health system administration. Most recently, she was CEO of the Virginia Commonwealth University (VCU) Health System (2015-2020), where she oversaw the opening of two out-patient care facilities, initiated the construction of a new children’s hospital, and partnered with the State of Virginia to open the Virginia Treatment Center, which focuses on in-patient child and adolescent psychiatry. Dr. Rappley was also responsible for the School of Dentistry, Health Professions, Medicine, Nursing, and Pharmacy as VCU’s Senior Vice President of Health Sciences. She was the first woman to serve in these roles at VCU.

Dr. Rappley previously held several administrative roles at Michigan State University’s (MSU) College of Human Medicine, where she became the first woman to serve as medical school Dean in Michigan. As Dean, she moved the medical school headquarters 60 miles to better position it for health system partnerships; established new campuses across the state, doubling the size; expanded the Rural Health Program; and established the Leadership in Medicine for the Underserved Program, all of which benefitted from her fundraising and resource partnership on behalf of MSU.

She has been recognized for her research in developmental and behavioral pediatrics and her institutional leadership. Currently, she is Chair of the LCME-AMA Council of the Liaison Committee on Medical Education (LCME). Her prior service includes the FDA, the American Board of Pediatrics, the Association for the Accreditation of Human Research Protection Programs,  the Association Academic Health Centers, the VCU Health System, and the Greater Grand Rapids YMCA. She served as Chair of the Council of Deans and Chair of the Board of Directors of the AAMC.

Dr. Rappley earned her medical degree from MSU and completed her residency at the University of Michigan’s Mott Children’s Hospital. She also holds a nursing degree from the University of Michigan.

Dean Emeritus, University of Pennsylvania

Dr. Arthur H. Rubenstein is Professor, Department of Medicine, Division of Endocrinology at the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania. Previously, Dr. Rubenstein was the Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine from September 2001 to July 2011. Together, these entities make up Penn Medicine, an enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care.

Before joining Penn, Dr. Rubenstein served for four years as Dean of Mount Sinai School of Medicine and Gustave L. Levy Distinguished Professor. Earlier, he was the Lowell T. Coggeshall Distinguished Service Professor of Medical Sciences and Chairman of the Department of Medicine at the University of Chicago Pritzker School of Medicine. Dr. Rubenstein is an internationally-prominent endocrinologist recognized for clinical expertise and groundbreaking research in diabetes. Well-known for his inspired teaching, Dr. Rubenstein has served in numerous professional leadership positions during his career.

Author of more than 350 publications, Dr. Rubenstein is the recipient of many awards and prizes, including the highest honor of the Association of American Physicians (AAP), the George M. Kober Medal and the highest honor from the Association of Professors of Medicine, the Robert H. Williams Distinguished Chair of Medicine Award. Among his other honors are the John Phillips Memorial Award from the American College of Physicians; the Banting Medal from the American Diabetes Association; and the David Rumbough Scientific Award from the Juvenile Diabetes Association. In 2009, Dr. Rubenstein was awarded the prestigious Abraham Flexner Award for Distinguished Service to Medical Education from the Association of American Medical Colleges. He was elected to membership in the Institute of Medicine in 1987.

Born in South Africa, Dr. Rubenstein received his medical degree from the University of the Witwatersrand in Johannesburg. In 2001, he was honored by his alma mater when an honorary degree, Doctor of Science in Medicine, was conferred upon him.

Past President, Josiah Macy Jr. Foundation

George E. Thibault, MD, became the seventh president of the Josiah Macy Jr. Foundation in January 2008. Immediately prior to that, he served as Vice President of Clinical Affairs at Partners Healthcare System in Boston and Director of the Academy at Harvard Medical School. Dr. Thibault was the first Daniel D. Federman Professor of Medicine and Medical Education at Harvard Medical School (HMS) and is now the Federman Professor Emeritus. Previously, he served as Chief Medical Officer at Brigham and Women’s Hospital and as Chief of Medicine at the Harvard affiliated Brockton/West Roxbury VA Hospital. He was Associate Chief of Medicine and Director of the Internal Medical Residency Program at the Massachusetts General Hospital (MGH).

For nearly four decades at HMS, Dr. Thibault played leadership roles in many aspects of undergraduate and graduate medical education. He played a central role in the New Pathway Curriculum reform and was a leader in the new Integrated Curriculum reform at HMS. He was the Founding Director of the Academy at HMS, which was created to recognize outstanding teachers and to promote innovations in medical education.

Throughout his career he has been recognized for his roles in teaching and mentoring medical students, residents, fellows and junior faculty. In addition to his teaching, his research has focused on the evaluation of practices and outcomes of medical intensive care and variations in the use of cardiac technologies.

Past President & CEO, Association of Academic Health Centers

Dr. Wartman served from 2005 – 2018 as the 3^rd President and CEO of the Association of Academic Health Centers (AAHC), a non-profit global association based in Washington DC that seeks to advance health and well-being through the vigorous leadership of the multifaceted institutions that educate the next generation of health professionals, conduct cutting edge biomedical and clinical research, and offer comprehensive patient care from the basic to the most advanced levels. Prior to assuming this position, he was Executive Vice President for Academic and Health Affairs and Dean of the School of Medicine at the University of Texas Health Science Center in San Antonio. Dr. Wartman’s career in academic medicine also includes chairing a department of medicine at two institutions and being the founding director of a division of general internal medicine.

Dr. Wartman, an internist and sociologist, is board certified in internal medicine and a Master of the American College of Physicians. He received his AB from Cornell University and his MD and PhD degrees from Johns Hopkins University. He was also a Robert Wood Johnson Clinical Scholar at Johns Hopkins and a Henry Luce Scholar in Indonesia.

He has made more than 150 visits to academic health centers and is recognized internationally for his work involving organization and management, problem-solving, strategic alignment, leadership development, and the changing dynamics of healthcare. He has also served as a mentor and confidential counselor to many leaders and aspiring leaders and has authored forward-thinking articles, books, and monographs involving the future of the health professions, the interface between medicine and machines, leadership development, and the need to reimagine medical education.

He has received numerous awards and honorary degrees, including the 2015 Johns Hopkins School of Medicine’s Distinguished Medical Alumnus Award and the 2018 Special Recognition Award of the Association of American Medical Colleges.

CEO and President, Colorado Longitudinal Study

Dr. Wise is CEO and president of the Colorado Longitudinal Study. She has been a passionate advocate for public research universities and the role they must play in meeting society’s greatest global challenges. With over thirty years of research funding from the National Institutes of Health, among other funding agencies, Dr. Wise’s research focuses on women’s health issues and how hormones influence learning and memory and protect the brain against neurodegeneration.

As chancellor at the University of Illinois at Urbana-Champaign and interim president and provost at the University of Washington, she led the development of shared visions and strategic plans that positioned these institutions for future decades.

Dr. Wise received her bachelor’s degree from Swarthmore College and her Ph.D. from the University of Michigan. She holds honorary degrees from Swarthmore College and the University of Birmingham (England).  She is an elected member of the National Academy of Medicine and the American Academy of Arts and Sciences.

Dr. Wise has significant corporate and foundation board experience and has served on the boards of directors of Nike and the First Busey Corp. In the non-profit sector, she serves on the boards of the Robert Wood Johnson Foundation and the Children’s Hospital Colorado, and the RAND Health boards of advisors. She was recognized as a “Woman of Influence” by the Puget Sound Business Journal and has received several awards that recognize her leadership in education, including the Asian Pacific Americans in Higher Education Leadership Award and the Chang-Lin Tien Educational Leadership Award.